Transoral Incisionless Fundoplication (TIF)
Treatment for GERD
Effectiveness
68%
Safety Score
60%
Clinical Trials
15
Participants
3K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Time to Effect
Weeks for full post-operative recovery
Treatment Duration
One-time procedure
Evidence Quality
MODERATENumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
100(Treat 100 patients to see 1 additional serious adverse event)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$150
Side Effect Mgmt:$150
Total Annual:$2,300
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$55,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$3,538.46
Cost per Remission
$4,600
Comparison vs Omeprazole (lifetime therapy)
Cost Difference
+$2,070/year
More expensive
QALY Difference
+0.07 QALYs
Better outcomes
Dominance
No dominance
Transoral Incisionless Fundoplication (TIF) Outcomes
for GERD
Efficacy Outcomes
Overall Effectiveness
+68%
Response Rate
+65%
Remission Rate
+50%
Common Side Effects
Dysphagia (transient)
+20%
Sore throat
+15%
Chest pain
+10%
Abdominal pain
+5%
Perforation
+0.1%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
3 active trials recruiting for Transoral Incisionless Fundoplication (TIF) in GERD
Observational Registry of Transoral Incisionless Fundoplication (TIF) for Gastroesophageal Reflux Disease (GERD)
NCT05066594RECRUITING
100 participants
OBSERVATIONAL
Milan, Italy
Started: May 1, 2021
European TIF2.0 Registry
NCT07395219ENROLLING BY INVITATION
500 participants
OBSERVATIONAL
Vienna, Austria +6 more
Started: Jan 1, 2023
Transoral Incisionless Fundoplication Database Repository (TIF)
NCT04306380ENROLLING BY INVITATION
500 participants
OBSERVATIONAL
Indianapolis, United States
Started: May 20, 2020
Completed Clinical Trials
6 completed trials for Transoral Incisionless Fundoplication (TIF) in GERD
Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD)
NCT01110811COMPLETEDNA
60 participants
INTERVENTIONAL
Leuven, Belgium +3 more
Started: Apr 1, 2010
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
NCT01118585COMPLETEDNA
278 participants
INTERVENTIONAL
Safford, United States +13 more
Started: May 1, 2010
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
NCT01136980COMPLETEDNA
129 participants
INTERVENTIONAL
Los Angeles, United States +8 more
Started: Apr 1, 2011
The EndoGastric Solutions TEMPO Trial
NCT01647958COMPLETEDNA
65 participants
INTERVENTIONAL
Redmond, United States
Started: Jun 1, 2012
Transoral Incisionless Fundoplication in Post-POEM GERD
NCT04770441COMPLETED
7 participants
OBSERVATIONAL
Houston, United States
Started: Mar 17, 2021
GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery
NCT03143608COMPLETED
99 participants
OBSERVATIONAL
Merrillville, United States +1 more
Started: May 1, 2014